Enter inventor name

Average Co-Inventor Count = 3.4

ph-index = 11

Forward Citations = 500(Granted Patents)

Company Filing History:

Genetics Institute, Inc.

patents

5 out of 2,597

University of Pennsylvania

patents

4. 1 out of 3,687

Johns Hopkins University

6. 4 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2006

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7122633 - Natural killer stimulatory factor (2006-10-17),

2. 6555658 - Antibodies to natural killer stimulatory factor (2003-04-29),

3. 6372208 - Method of reducing an immune response to a recombinant virus (2002-04-16),

4. 6300478 - Antibodies to natural killer stimulatory factor (2001-10-09),

5. 6251957 - Method of reducing an immune response to a recombinant virus (2001-06-26),

6. 6168923 - Compositions and methods for use of IL-12 as an adjuvant (2001-01-02),

7. 6086876 - Methods and compositions for the inhibition of interleukin-12 production (2000-07-11),

8. 5976539 - Compositions and methods for use of IL-12 as an adjuvant (1999-11-02),

9. 5872154 - Method of reducing an immune response to a recombinant adenovirus (1999-02-16),

10. 5811523 - Antibodies to natural killer stimulatory factor (1998-09-22),

11. 5723127 - Compositions and methods for use of IL-12 as an adjuvant (1998-03-03),

12. 5688690 - Human cytotoxic lymphocyte signal transduction surface protein (P38) and (1997-11-18),

13. 5648467 - Natural killer cell stimulatory factor (1997-07-15),

14. 5648072 - Methods of inducing gamma interferon and stimulating blood cell (1997-07-15),

15. 5571515 - Compositions and methods for use of IL-12 as an adjuvant (1996-11-05),

Title: The Innovations of Giorgio Trinchieri

Introduction

Giorgio Trinchieri is a notable inventor based in Wynnewood, PA (US). He has made significant contributions to the field of immunology, particularly through his work on natural killer cells and cytokines. With a total of 17 patents, Trinchieri's innovations have had a profound impact on medical research and therapeutic applications.

Latest Patents

Trinchieri's latest patents include groundbreaking work on Natural Killer Stimulatory Factor (NKSF). One of his applications relates to antibodies that are reactive with this novel homogenous human cytokine. These antibodies have the ability to induce the production of gamma interferon in vitro in human peripheral blood lymphocytes. Additionally, he has developed a pharmaceutical preparation containing such antibodies, which could have significant implications for immune response modulation.

Career Highlights

Throughout his career, Giorgio Trinchieri has worked with esteemed organizations such as Genetics Institute, Inc. and the University of Pennsylvania. His research has been pivotal in advancing our understanding of immune mechanisms and developing new therapeutic strategies.

Collaborations

Trinchieri has collaborated with notable colleagues in his field, including Bice Perussia and Michiko Kobayashi. These partnerships have further enriched his research and contributed to the advancement of immunological studies.

Conclusion

Giorgio Trinchieri's contributions to the field of immunology through his patents and collaborations highlight his role as a leading inventor. His work continues to influence medical research and therapeutic innovations.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com